ArticleBreast cancer research and treatment2020

Myxovirus resistance 1 (MX1) is an independent predictor of poor outcome in invasive breast cancer.

Abrar I Aljohani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.